(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

A

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

A

ST13

US500000078849310

Class

40, 42

Filing

78849310

Registration

3500208

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

09/11/2018

Trademark type

Combined

Nice classes

40, 42

Filing date

03/29/2006

Registration date

09/09/2008

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/11/2018

Last transaction

09/11/2018

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

08/07/2006

First use in commerce

08/07/2006

Drawing code

3

Owner type

11

Owner location

BUBENDORF, CH

Examiner

RITTNER, HANNO

Law office

M80

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of stylized lowercase letters "a" and "c".

Holders and representatives

Holders

DISHMAN PHARMA SOLUTIONS AG
SOLUTIA INC.

Representatives

Boris Umansky LADAS & PARRY LLP

Technical classification

Nice Classes

Class 40Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 40

Custom manufacture for others of pharmaceuticalspharmaceutical ingredients and chemical products and chemical intermediates

Class 42

Chemical and pharmaceutical research and development for others; research and development for others of processes for production of pharmaceuticalspharmaceutical ingredients and other chemicals; chemical analysis for others; consultancy services in the fields of pharmaceuticals and chemical products

Publications

History of USPTO decisions and trademark events.

34 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

09/11/2018

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

09/11/2018

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

09/11/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/11/2018

E89R

TEAS SECTION 8 & 9 RECEIVED

08/31/2018

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

09/09/2017

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

07/24/2014

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

07/23/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/23/2014

E815

TEAS SECTION 8 & 15 RECEIVED

07/08/2014

R.PR

REGISTERED-PRINCIPAL REGISTER

09/09/2008

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

08/06/2008

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/06/2008

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/05/2008

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/05/2008

IUAF

USE AMENDMENT FILED

07/07/2008

MAIL

PAPER RECEIVED

07/07/2008

EX1G

SOU EXTENSION 1 GRANTED

12/31/2007

EXT1

SOU EXTENSION 1 FILED

12/31/2007

EEXT

SOU TEAS EXTENSION RECEIVED

12/31/2007

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

07/10/2007

PUBO

PUBLISHED FOR OPPOSITION

04/17/2007

NPUB

NOTICE OF PUBLICATION

03/28/2007

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/26/2007

ALIE

ASSIGNED TO LIE

02/26/2007

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/22/2007

XAEC

EXAMINER'S AMENDMENT ENTERED

01/22/2007

GNEA

EXAMINERS AMENDMENT E-MAILED

01/22/2007

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/22/2007

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

11/15/2006

GPRA

PRIORITY ACTION E-MAILED

09/12/2006

CPRA

PRIORITY ACTION WRITTEN

09/12/2006

DOCK

ASSIGNED TO EXAMINER

09/12/2006

NWAP

NEW APPLICATION ENTERED

04/04/2006

Continuous trademark protection

Get notified about every new filing that threatens A or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.